bicalutamide has been researched along with Bone Cancer in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (20.00) | 18.2507 |
| 2000's | 14 (40.00) | 29.6817 |
| 2010's | 12 (34.29) | 24.3611 |
| 2020's | 2 (5.71) | 2.80 |
| Authors | Studies |
|---|---|
| Ichikawa, T; Imamura, Y; Kamada, S; Komiya, A; Nakamura, K; Nakatsu, H; Rii, J; Sakamoto, S; Yamada, Y; Yamamoto, S | 1 |
| Schattner, A | 1 |
| Ferlicot, S | 1 |
| Kagawa, M; Kawakami, S; Morozumi, M; Okada, Y; Takeshita, H; Yano, A | 1 |
| Dalgleish, AG; Di Palma, S; Fusi, A; Nathan, K; Patel, N; Powell, B | 1 |
| Chung, J; Chung, JM; Ha, YS; Jung, YS; Kang, DI; Kim, IY; Kim, TH; Kim, WJ; Lee, DH; Lee, GT; Min, K; Moon, KH | 1 |
| Duensing, S; Grüllich, C; Hadaschik, BA; Höfner, T; Hohenfellner, M; Jäger, D; Pahernik, S; Vallet, S | 1 |
| Cacalano, NA; Godebu, E; Hirata, T; Jamieson, CA; Kulidjian, AA; Liss, MA; Ma, W; Muldong, M; Park, SC; Raheem, O; Strasner, A; Woo, JR; Wu, CN | 1 |
| Choufani, E; Manov, A; Subramaniam, S | 1 |
| Esa, A; Hara, I; Iki, M; Imanishi, M; Kajikawa, H; Komura, T; Matsuyama, H; Nagao, K; Nishioka, T; Nozawa, M; Ogawa, T; Uejima, S; Uekado, Y; Uemura, H | 1 |
| Bassi, P; Brescia, A; Gardi, M; Gulino, G; Pinto, F; Sacco, E; Volpe, A | 1 |
| Chan, MM; Cheng, CW; Kanesvaran, R; Khoo, D; Phipps, C; Tan, MH | 1 |
| Jaspers, HC; Mattijssen, V; Schoffelen, R; Slootweg, PJ; van der Graaf, WT; van Herpen, CM; Verbist, BM | 1 |
| Masago, T; Motoda, K; Nemoto, R; Watanabe, T | 1 |
| Beer, TM; Drake, CG; Graff, JN | 1 |
| Smith, MR | 1 |
| Akaza, H; Arai, Y; Igawa, M; Kanetake, H; Kumon, H; Matsuda, T; Naito, S; Ohashi, Y; Soeda, A; Usami, M; Yamaguchi, A | 1 |
| Nakamura, M; Sakai, N; Shioi, K; Yoshida, M | 1 |
| Le, BH; Rosenthal, MA | 1 |
| Daskivich, TJ; Oh, WK | 1 |
| Armstrong, J; Chodak, GW; Iverson, P; McLeod, D; Morris, C; See, WA; Warren, KS; Wirth, M | 1 |
| Higashihara, E; Kinjo, M; Nutahara, K; Okegawa, T | 1 |
| Barbón, JJ; Gay, LL; González-Tuero, J; Pérez-García, FJ; Sampedro, A | 1 |
| Bradley, DA; Chenevert, TL; Galban, CJ; Hussain, M; Jacobson, JA; Johnson, TD; Lee, KC; Meyer, CR; Pienta, KJ; Rehemtulla, A; Ross, BD | 1 |
| Chapman, RA; Crawford, ED; Eisenberger, MA; Fontana, JA; Hussain, MH; Mills, GM; Parab, M; Raghavan, D; Sartor, AO; Tangen, CM | 1 |
| Akaza, H; Arai, Y; Deguchi, T; Fujisawa, M; Hayashi, M; Hirao, Y; Kanetake, H; Naito, S; Namiki, M; Ohashi, Y; Tachibana, M; Usami, M | 1 |
| Kaisary, AV | 1 |
| Brett, C; Kelly, WK; Kolvenbag, G; Liebertz, C; Mazumdar, M; Scher, HI; Schwartz, L; Schwartz, M; Shapiro, L | 1 |
| Anderson, JB; Baert, L; Blackledge, G; Chamberlain, M; Iversen, P; Kaisary, AV; Tammela, T; Tyrrell, CJ; Webster, A | 1 |
| Block, NL; Kelley, RP; Kolvenbag, GJ; McLeod, DG; Patterson, AL; Sarosdy, MF; Schellhammer, PF; Sharifi, R; Soloway, MS; Venner, PM; Vogelzang, NJ | 1 |
| Bushnell, DL; Kahn, D; Madsen, M; Nathan, M; Williams, RD | 1 |
| Aguayo, J; Cole, A; Martin, E; Mathew, A; Mendelblatt, D; Vesely, DL | 1 |
| Carducci, MA; Eisenberger, MA; Laufer, M; Sinibaldi, VJ | 1 |
| Furuya, Y; Fuse, H; Nagakawa, O; Nozaki, T | 1 |
| Newling, DW | 1 |
3 review(s) available for bicalutamide and Bone Cancer
| Article | Year |
|---|---|
[Prostate cancer histoseminar: Update of the 2016 WHO classification - case n
Topics: Adenocarcinoma; Aged, 80 and over; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Fatal Outcome; Humans; Leuprolide; Lower Urinary Tract Symptoms; Male; Nitriles; Prostatectomy; Prostatic Neoplasms; Tosyl Compounds | 2017 |
Disseminated intravascular coagulation secondary to metastatic prostate cancer: case report and review of the literature.
Topics: Adenocarcinoma; Anilides; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Diagnosis, Differential; Disseminated Intravascular Coagulation; Ecchymosis; Femur; Hematuria; Humans; Leuprolide; Male; Middle Aged; Nitriles; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome | 2009 |
Osteoporosis during androgen deprivation therapy for prostate cancer.
Topics: Aged; Androgen Antagonists; Anilides; Bone and Bones; Bone Density; Bone Neoplasms; Estrogens; Fractures, Bone; Humans; Male; Middle Aged; Nitriles; Osteoporosis; Prostatic Neoplasms; Testosterone; Tosyl Compounds | 2002 |
9 trial(s) available for bicalutamide and Bone Cancer
| Article | Year |
|---|---|
Significance of baseline bone markers on disease progression and survival in hormone-sensitive prostate cancer with bone metastasis.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Alkaline Phosphatase; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Bone Neoplasms; Diphosphonates; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Therapy, Combination; Follow-Up Studies; Goserelin; Humans; Imidazoles; Japan; Male; Middle Aged; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Risk Factors; Survival Rate; Time Factors; Tosyl Compounds; Zoledronic Acid | 2015 |
Superior anti-tumor efficacy of bicalutamide 80 mg in combination with a luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist monotherapy as first-line treatment for advanced prostate cancer: interim results of a randomized study in Ja
Topics: Aged; Anilides; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disease-Free Survival; Double-Blind Method; Goserelin; Humans; Japan; Leuprolide; Lymphatic Metastasis; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Tosyl Compounds; Treatment Outcome | 2004 |
Antiandrogen withdrawal in castrate-refractory prostate cancer: a Southwest Oncology Group trial (SWOG 9426).
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Bone Neoplasms; Disease-Free Survival; Flutamide; Gonadotropin-Releasing Hormone; Humans; Imidazolidines; Male; Middle Aged; Nitriles; Orchiectomy; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome; Survival Rate; Tosyl Compounds | 2008 |
Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: a multicenter, randomized, double-blind, comparative study.
Topics: Aged; Androgen Antagonists; Anilides; Bone Neoplasms; Double-Blind Method; Gonadotropin-Releasing Hormone; Humans; Lymphatic Metastasis; Male; Neoplasm Staging; Nitriles; Prognosis; Prostatic Neoplasms; Quality of Life; Survival Rate; Tosyl Compounds; Treatment Outcome | 2008 |
Current clinical studies with a new nonsteroidal antiandrogen, Casodex.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents; Bone Neoplasms; Humans; Male; Middle Aged; Nitriles; Prostatic Neoplasms; Survival Analysis; Tosyl Compounds; Treatment Outcome | 1994 |
A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Bone Neoplasms; Castration; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Nitriles; Probability; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Survival Rate; Tosyl Compounds; Treatment Outcome | 1998 |
Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study Group.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Black People; Bone Neoplasms; Cohort Studies; Disease Progression; Disease-Free Survival; Double-Blind Method; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Middle Aged; Nitriles; Prostatic Neoplasms; Tosyl Compounds; White People | 1999 |
Enhanced uptake of 99Tcm-MDP in skeletal metastases from prostate cancer following initiation of hormone treatment: potential for increasing delivery of therapeutic agents.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Anilides; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Gonadotropin-Releasing Hormone; Hormones; Humans; Male; Nitriles; Osteocalcin; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tosyl Compounds | 1999 |
The response of advanced prostatic cancer to a new non-steroidal antiandrogen: results of a multicenter open phase II study of Casodex. European/Australian Co-operative Group.
Topics: Aged; Aged, 80 and over; Anilides; Bone Neoplasms; Breast; Dizziness; Drug Evaluation; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 1990 |
23 other study(ies) available for bicalutamide and Bone Cancer
| Article | Year |
|---|---|
How many bone metastases may be defined as high-volume metastatic prostate cancer in Asians: A retrospective multicenter cohort study.
Topics: Aged; Aged, 80 and over; Anilides; Asian People; Bone Neoplasms; Cohort Studies; Gonadotropin-Releasing Hormone; Humans; Japan; Male; Middle Aged; Nitriles; Prognosis; Progression-Free Survival; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Retrospective Studies; Tosyl Compounds | 2020 |
Sense and Sensibility.
Topics: Androgen Antagonists; Anilides; Bone Neoplasms; Decision Making, Shared; Humans; Hypocalcemia; Male; Nitriles; Patient Preference; Physician-Patient Relations; Professional-Family Relations; Prostatic Neoplasms; Tosyl Compounds | 2021 |
Baseline low serum dehydroepiandrosterone sulfate can predict poor responsiveness to hormone therapy in patients with hormone-naïve prostate cancer with skeletal metastases.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Bone Neoplasms; Dehydroepiandrosterone Sulfate; Humans; Male; Middle Aged; Nitriles; Predictive Value of Tests; Prostatic Neoplasms; Tosyl Compounds | 2017 |
The successful treatment of metastatic androgen receptor-positive tumours of parotid origin with androgen receptor blockade and immunotherapy.
Topics: Adenocarcinoma; Adult; Aged; Androgen Receptor Antagonists; Androstenes; Anilides; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Bone Neoplasms; Cancer Vaccines; Humans; Male; Nitriles; Parotid Neoplasms; Receptors, Androgen; Tosyl Compounds | 2019 |
Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction.
Topics: Adult; Androgen Antagonists; Anilides; Bone Morphogenetic Protein 6; Bone Neoplasms; Cell Communication; Cell Growth Processes; Cell Line, Tumor; Humans; Male; Middle Aged; Neoplasm Metastasis; Nitriles; Orchiectomy; Prostatic Neoplasms, Castration-Resistant; Proto-Oncogene Proteins; Receptors, Androgen; Retrospective Studies; Stromal Cells; Tosyl Compounds; Wnt Proteins; Wnt-5a Protein | 2014 |
Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: efficacy and predictive parameters in a large single center cohort.
Topics: Aged; Androgen Antagonists; Androstenes; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Cohort Studies; Disease-Free Survival; Docetaxel; Flutamide; Humans; Leuprolide; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nitriles; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Taxoids; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate | 2015 |
PCSD1, a new patient-derived model of bone metastatic prostate cancer, is castrate-resistant in the bone-niche.
Topics: Androgen Antagonists; Anilides; Animals; Bone Neoplasms; Disease Models, Animal; Heterografts; Humans; Male; Mice; Nitriles; Orchiectomy; Prostatic Neoplasms; Tosyl Compounds | 2014 |
Lack of energy, petechiae, elevated PSA level--Dx?
Topics: Adenocarcinoma; Anilides; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Bone Neoplasms; Diagnosis, Differential; Fatigue; Glucocorticoids; Humans; Leuprolide; Male; Middle Aged; Nitriles; Plasma Exchange; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Purpura; Purpura, Thrombotic Thrombocytopenic; Thoracic Vertebrae; Tomography, X-Ray Computed; Tosyl Compounds; Treatment Outcome | 2014 |
Management of thrombotic thrombocytopenic purpura in metastatic prostate cancer with only endocrine therapy.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Bone Neoplasms; Goserelin; Humans; Male; Middle Aged; Nitriles; Prostatic Neoplasms; Purpura, Thrombotic Thrombocytopenic; Tosyl Compounds | 2010 |
Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment options.
Topics: Anilides; Antineoplastic Agents; Bone Neoplasms; Brain Neoplasms; Carcinoma, Ductal; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nitriles; Receptors, Androgen; Salivary Ducts; Salivary Gland Neoplasms; Tosyl Compounds | 2011 |
Interstitial pneumonitis induced by bicalutamide given for prostate cancer.
Topics: Aged; Androgen Antagonists; Anilides; Bone Neoplasms; Castration; Humans; Lung Diseases, Interstitial; Male; Nitriles; Paralysis; Prednisolone; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds | 2011 |
Complete biochemical (prostate-specific antigen) response to sipuleucel-T with enzalutamide in castration-resistant prostate cancer: a case report with implications for future research.
Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Cancer Vaccines; Gonadotropin-Releasing Hormone; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Nitriles; Phenylthiohydantoin; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Tissue Extracts; Tosyl Compounds; Treatment Outcome | 2013 |
Successful recovery from interstitial pneumonitis, induced by bicalutamide and leuprorelin acetate given as treatment for prostate cancer.
Topics: Adenocarcinoma; Aged; Anilides; Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Bone Neoplasms; Humans; Leuprolide; Lung Diseases, Interstitial; Male; Methylprednisolone Hemisuccinate; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 2005 |
Prostate cancer presenting with fever and rigors.
Topics: Aged, 80 and over; Androgen Antagonists; Anilides; Bone Neoplasms; Fever; Follow-Up Studies; Humans; Male; Nitriles; Prostatic Neoplasms; Shivering; Tomography, X-Ray Computed; Tosyl Compounds | 2005 |
Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: insight into mechanisms?
Topics: Abscess; Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Bone Neoplasms; Delayed-Action Preparations; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Nitriles; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone; Tosyl Compounds; Treatment Failure | 2006 |
Are bone scans necessary in men with low prostate specific antigen levels following localized therapy?
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Humans; Male; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radionuclide Imaging; Randomized Controlled Trials as Topic; Tosyl Compounds | 2006 |
Pretreatment serum level of HER2/nue as a prognostic factor in metastatic prostate cancer patients about to undergo endocrine therapy.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Biomarkers, Tumor; Bone Neoplasms; Disease-Free Survival; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Nitriles; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Receptor, ErbB-2; Retrospective Studies; Survival Rate; Tosyl Compounds; Treatment Outcome | 2006 |
[Regression of a choroidal metastasis from prostate adenocarcinoma after hormonal therapy].
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biopsy; Bone Neoplasms; Choroid Neoplasms; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Nitriles; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Time Factors; Tosyl Compounds; Treatment Outcome | 2007 |
A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone.
Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Body Water; Bone Neoplasms; Cell Membrane Permeability; Diffusion Magnetic Resonance Imaging; Feasibility Studies; Goserelin; Humans; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Radionuclide Imaging; Tomography, X-Ray Computed; Tosyl Compounds; Treatment Outcome; Whole Body Imaging | 2007 |
Bicalutamide for advanced prostate cancer: the natural versus treated history of disease.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents, Hormonal; Bone and Bones; Bone Neoplasms; Disease Progression; Flutamide; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Radionuclide Imaging; Tosyl Compounds | 1997 |
Metastatic prostate cancer (with prostate-specific antigen of 9996) presenting as obstructive jaundice.
Topics: Aged; Alkaline Phosphatase; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Bone Neoplasms; Cholestasis; Humans; Leuprolide; Lymphatic Metastasis; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome | 2000 |
Rapid disease progression after the administration of bicalutamide in patients with metastatic prostate cancer.
Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Bone Neoplasms; Disease Progression; Humans; Male; Middle Aged; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds | 1999 |
Low serum testosterone level predicts worse response to endocrine therapy in Japanese patients with metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Anilides; Antineoplastic Agents, Hormonal; Bone Neoplasms; Chlormadinone Acetate; Diethylstilbestrol; Disease Progression; Flutamide; Gonadotropin-Releasing Hormone; Humans; Japan; Male; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Neoplasms; Statistics, Nonparametric; Testosterone; Tosyl Compounds | 2002 |